Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tissue plasminogen activator |
Is a |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Single chain urokinase-like plasminogen activator |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|
Poisoning by urokinase |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Accidental urokinase poisoning |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Intentional urokinase poisoning (disorder) |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
intoxication par l'urokinase d'intention indéterminée |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Allergy to urokinase (finding) |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Urokinase overdose |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Accidental urokinase overdose |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Intentional urokinase overdose |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
surdose d'urokinase d'intention indéterminée |
Causative agent (attribute) |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Product containing urokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Urokinase 50000units/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Urokinase (substance) |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|
Anistreplase (substance) |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase (substance) |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|
Product containing plasminogen activator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Plasminogen activator |
Inferred relationship |
Some |
1 |
Product containing anistreplase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Product containing streptokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
streptokinase 1 500 000 U.I., fiole de poudre pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
streptokinase 250 000 U.I., fiole de poudre pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
streptokinase 750 000 U.I., fiole de poudre pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Product containing urokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase+streptodornase 100,000/25,000units topical powder+kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase+streptodornase 100,000/25,000units topical powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Urokinase 5000 unit/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Product containing streptodornase and streptokinase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Anistreplase 30unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Urokinase 50000units/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase 600000iu/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase 750000unt intravenous infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase 1500000unt intravenous infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Streptokinase 250000unt intravenous infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plasminogen activator |
Inferred relationship |
Some |
|
Tenecteplase (substance) |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|
Alteplase (substance) |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|
Reteplase (substance) |
Is a |
True |
Plasminogen activator |
Inferred relationship |
Some |
|